SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-019022
Filing Date
2023-11-14
Accepted
2023-11-14 16:10:40
Documents
73
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ampe-20230930x10q.htm   iXBRL 10-Q 1525864
2 EX-31.1 ampe-20230930xex31d1.htm EX-31.1 16193
3 EX-31.2 ampe-20230930xex31d2.htm EX-31.2 16168
4 EX-32.1 ampe-20230930xex32d1.htm EX-32.1 9418
5 GRAPHIC ampe-20230930x10q002.jpg GRAPHIC 3040
  Complete submission text file 0001558370-23-019022.txt   6672901

Data Files

Seq Description Document Type Size
6 EX-101.SCH ampe-20230930.xsd EX-101.SCH 49572
7 EX-101.CAL ampe-20230930_cal.xml EX-101.CAL 42882
8 EX-101.DEF ampe-20230930_def.xml EX-101.DEF 182366
9 EX-101.LAB ampe-20230930_lab.xml EX-101.LAB 337653
10 EX-101.PRE ampe-20230930_pre.xml EX-101.PRE 310788
67 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20230930x10q_htm.xml XML 1315332
Mailing Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112
Business Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 231406205
SIC: 2834 Pharmaceutical Preparations